glp-1 agonists cardiovascular diseases The Biology of Glucagon-like Peptide-1 Cardiovascular Effects of Glucagon-Like Peptide-1
Description
Chan DC, Watts GF, Ng TWK, Yamashita S, Barrett PHR
10.1038/s42255-023-00812-z 98 OforiJ
Instead, all weight loss causes the loss of muscle tissue
Front Endocrinol (2021) 12:721135
247 The primary action often occurs through indirect mechanisms, such as insulin and somatostatin
